Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Exudative Age Related Macular Degeneration”

559 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 559 results

Large-scale testing (Phase 3)Temporarily pausedNCT00460967
What this trial is testing

Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis

Who this might be right for
Age-Related Maculopathy
OccuLogix 325
Testing effectiveness (Phase 2)Study completedNCT02462889
What this trial is testing

IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD

Who this might be right for
Age-Related Macular Degeneration
Jeffrey S Heier 128
Not applicableStudy completedNCT00088192
What this trial is testing

Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Eyetech Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT01327222
What this trial is testing

Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Age Related Macular Degeneration
IRCCS San Raffaele 20
Not applicableEnded earlyNCT05266495
What this trial is testing

Effectiveness of Brolucizumab in Pre-treated Patients With nAMD in the Real-world Setting

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 3
Testing effectiveness (Phase 2)Study completedNCT03744767
What this trial is testing

Adjuvant Anti-Mineralocorticoid-Receptor Treatment in Anti-VEGF Refractory Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Dr Irmela MANTEL 20
Not applicableNot Yet RecruitingNCT07004361
What this trial is testing

Ethical Issues of Using Gene Therapy in the Treatment of AMD

Who this might be right for
Exudative Age-related Macular Degeneration
Nantes University Hospital 30
Early research (Phase 1)Study completedNCT03144999
What this trial is testing

Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59

Who this might be right for
Dry Age-related Macular Degeneration
Janssen Research & Development, LLC 17
Testing effectiveness (Phase 2)Looking for participantsNCT05769153
What this trial is testing

Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Alcon Research 140
Post-approval studies (Phase 4)Study completedNCT01896284
What this trial is testing

Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth Factor

Who this might be right for
Wet Macular Degeneration
Barcelona Macula Foundation 46
Not applicableStudy completedNCT02287298
What this trial is testing

Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment

Who this might be right for
Exudative Macular Degeneration
The Retina Center of St. Louis County, PC 400
Not applicableStudy completedNCT05281042
What this trial is testing

Home OCT Repeatability and Reproducibility of Automatic Fluid Quantification Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Notal Vision Inc. 20
Not applicableUnknownNCT01310686
What this trial is testing

Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy

Who this might be right for
Wet AMD
West Coast Retina Medical Group, Inc. 40
Not applicableWithdrawnNCT00447031
What this trial is testing

Combination Therapy for Neovascular Age Related Macular Degeneration

Who this might be right for
Macular Degeneration
Yonsei University
Testing effectiveness (Phase 2)Study completedNCT01242254
What this trial is testing

A Study Assessing the Safety and Efficacy of Multiple Intravitreal KH902 in Patients With CNV Due to AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 36
Early research (Phase 1)Study completedNCT02859766
What this trial is testing

Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With Neovascular AMD

Who this might be right for
Macular Degeneration
Allergan 30
Testing effectiveness (Phase 2)Study completedNCT04200248
What this trial is testing

A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Ribomic USA Inc 94
Post-approval studies (Phase 4)Active Not RecruitingNCT06795048
What this trial is testing

Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Hoffmann-La Roche 274
Large-scale testing (Phase 3)Study completedNCT04516278
What this trial is testing

A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders

Who this might be right for
Age-related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration+2 more
Outlook Therapeutics, Inc. 195
Early research (Phase 1)Study completedNCT00569140
What this trial is testing

A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Ophthotech Corporation 18
Load More Results